循环德克斯林衍生物降低过渡性受体潜在的瓦尼洛伊德1和Ankyrin1离子通道激活通过改变周围的膜微环境通过胆固醇消耗减少胆固醇
Andrea Kinga Nehr-Majoros1,2,3, János Erostyák4,5, Éva Fenyvesi6
1Department of Pharmacology and Pharmacotherapy, Medical School and Centre for Neuroscience, University of Pécs, Pécs, Hungary.
Frontiers in cell and developmental biology
|March 14, 2024
概括
环极素可以从细胞膜中消耗胆固醇,抑制与疼痛相关的TRPV1和TRPA1通道. 非甲基化衍生物显示出更好的安全性,为新的外周作用止痛药提供了潜在的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 暂时受体潜在的瓦尼洛伊德1 (TRPV1) 和安基林1 (TRPA1) 通道对于疼痛信号至关重要,它们位于脂质中.
- 破坏这些脂质可以减少TRP通道的激活,并产生止痛作用.
研究的目的:
- 研究不同环极素 (CD) 衍生物对细胞活力,膜性质和TRPV1/TRPA1通道活性的影响.
- 评估甲基化与非甲基化CD衍生物的安全性和有效性.
主要方法:
- 用8种不同的甲基化和非甲基化CD衍生物对细胞进行处理.
- 评估细胞活力和线粒体膜潜力.
- 对细胞膜组成的分析,特别是胆固醇水平.
- 测量TRPV1和TRPA1激动剂诱导的 (Ca2+) 流入.
主要成果:
- 非甲基化CD衍生品比甲基化CD衍生品具有更好的安全性.
- 甲基化CD衍生物降低了线粒体膜潜力.
- 所有测试的CD衍生品都减少了膜胆固醇,改变了膜结构,并通过TRPV1和TRPA1道分别抑制了素和基异硫酸诱导的Ca2+流入.
结论:
- 环极素通过改变膜脂组成来调节TRPV1和TRPA1通道活性.
- 非甲基化环极是更安全的,并可能为治疗疼痛提供治疗策略.
- 这种机制为开发针对可感知信号的外周作用止痛药提供了基础.
相关概念视频
01:12GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
01:23Membrane Fluidity
152.2K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
152.2K
01:20Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
625
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
625
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
515
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
515
01:39Receptor-mediated Endocytosis
104.4K
Overview
104.4K